glp-1 companion app companies Hims & @Hers is expanding its ambitions. The telehealth giant has acquired European platform @Eucalyptus.Health as it pushes further into weight care, just as new FDA developments could reshape the future Jurni GLP | GLP-1 Companion
Description
What far fewer people realize is that a daily oral GLP-1 receptor agonist has entered the picture, and it is not simply a rebranded version of existing medications
This early checkpoint provides a practical opportunity to reassess treatment strategies rather than continuing ineffective interventions
Be patient with cosmetic changes
That is the core principle of our GLP-1 Body Blueprint
Clinical trials of Rybelsus primarily documented gastrointestinal side effects such as nausea, vomiting, diarrhoea, and abdominal pain as the most frequent adverse reactions
